Healthcare provider profile · identity verified

Jesse Albert Heuer, DO

Family Practice · ALBANY, OR · NPI 1487831848

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	176
Amlodipine Besylate	Amlodipine Besylate	309	118
Lisinopril	Lisinopril	306	110
Levothyroxine Sodium	Levothyroxine Sodium	272	85
Omeprazole	Omeprazole	235	92
Losartan Potassium	Losartan Potassium	231	91
Gabapentin	Gabapentin	202	62
Metoprolol Succinate	Metoprolol Succinate	191	67
Albuterol Sulfate Hfa	Albuterol Sulfate	175	72
Tamsulosin Hcl	Tamsulosin Hcl	152	50
Metformin Hcl	Metformin Hcl	136	49
Warfarin Sodium	Warfarin Sodium	124	29
Pantoprazole Sodium	Pantoprazole Sodium	123	41
Hydrochlorothiazide	Hydrochlorothiazide	122	51
Potassium Chloride	Potassium Chloride	106	36
Furosemide	Furosemide	104	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	33
Metformin Hcl Er	Metformin Hcl	101	36
Eliquis	Apixaban	98	30
Sertraline Hcl	Sertraline Hcl	98	30
Trazodone Hcl	Trazodone Hcl	97	31
Rosuvastatin Calcium	Rosuvastatin Calcium	76	32
Pravastatin Sodium	Pravastatin Sodium	71	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	19
Citalopram Hbr	Citalopram Hydrobromide	63	23
Fluoxetine Hcl	Fluoxetine Hcl	63	22
Duloxetine Hcl	Duloxetine Hcl	62	21
Allopurinol	Allopurinol	59	18
Carvedilol	Carvedilol	55	18
Fluticasone Propionate	Fluticasone Propionate	54	26
Ozempic	Semaglutide	54	15
Simvastatin	Simvastatin	52	24
Jardiance	Empagliflozin	50	15
Metoprolol Tartrate	Metoprolol Tartrate	48	19
Tizanidine Hcl	Tizanidine Hcl	48	17
Clopidogrel	Clopidogrel Bisulfate	47	15
Ondansetron Odt	Ondansetron	47	27
Oxycodone Hcl	Oxycodone Hcl	43	17
Pregabalin	Pregabalin	41	suppressed
Torsemide	Torsemide	41	18
Famotidine	Famotidine	40	12
Finasteride	Finasteride	40	14
Mirtazapine	Mirtazapine	40	14
Montelukast Sodium	Montelukast Sodium	39	19
Hydroxyzine Hcl	Hydroxyzine Hcl	37	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	15
Alprazolam	Alprazolam	36	suppressed
Baclofen	Baclofen	36	12
Spironolactone	Spironolactone	36	15
Tramadol Hcl	Tramadol Hcl	36	18
Lamotrigine	Lamotrigine	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Lovastatin	Lovastatin	33	11
Incruse Ellipta	Umeclidinium Bromide	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Bupropion Xl	Bupropion Hcl	31	16
Escitalopram Oxalate	Escitalopram Oxalate	31	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	15
Prazosin Hcl	Prazosin Hcl	31	suppressed
Atenolol	Atenolol	29	14
Lorazepam	Lorazepam	29	14
Xarelto	Rivaroxaban	29	suppressed
Meloxicam	Meloxicam	28	13
Buspirone Hcl	Buspirone Hcl	27	suppressed
Prednisone	Prednisone	26	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	22
Meclizine Hcl	Meclizine Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Cephalexin	Cephalexin	24	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	18
Clonidine Hcl	Clonidine Hcl	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	19
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Glipizide	Glipizide	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Risperidone	Risperidone	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Colchicine	Colchicine	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Azithromycin	Azithromycin	15	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Irbesartan	Irbesartan	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error